Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today?
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The big news today is Telomir-1's ability to reverse epigenetic gene silencing in aggressive human prostate cancer cells. This revelation comes from a study of these cells in mice. Telomir Pharmaceuticals noted that Telomir-1 outperformed Paclitaxel and Rapamycin, two cancer treatments, in this study.
Telomir Pharmaceuticals CEO Erez Aminov said, 'This study provides novel and direct molecular evidence of Telomir-1's ability to reprogram cancer epigenetics. By potentially restoring the function of key tumor suppressor genes like STAT1, we're not just slowing tumor growth-we're turning the immune system back on.'
Telomir Pharmaceuticals Stock Movement Today
Telomir Pharmaceuticals stock was up 152.07% on Friday, extending a 5.22% rally from yesterday. Even so, the shares have fallen 70.63% year to date and 67.73% over the past 12 months. Today's rally came with heavy trading, as some 57 million shares changed hands, compared to a three-month daily average of about 381,000 units.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
4 hours ago
- Business Wire
BitGo Announces Confidential Submission of Draft Registration Statement to SEC for Proposed Initial Public Offering
NEW YORK--(BUSINESS WIRE)--BitGo Holdings, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 to the Securities and Exchange Commission (the 'SEC') relating to the proposed initial public offering of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the 'Securities Act'). This announcement is being issued in accordance with Rule 135 under the Securities Act.
Business Insider
6 hours ago
- Business Insider
Analysts Offer Insights on Communication Services Companies: Telia Company AB (OtherTLSNF) and Prosus (OtherPROSF)
Companies in the Communication Services sector have received a lot of coverage today as analysts weigh in on Telia Company AB (TLSNF – Research Report) and Prosus (PROSF – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Telia Company AB (TLSNF) Barclays analyst Maurice Patrick maintained a Sell rating on Telia Company AB today and set a price target of SEK33.00. The company's shares closed last Wednesday at $3.50, equals to its 52-week high of $3.50. According to Patrick is ranked #2977 out of 9889 analysts. Currently, the analyst consensus on Telia Company AB is a Hold with an average price target of $3.55. Prosus (PROSF) In a report released today, Marcus Diebel from J.P. Morgan maintained a Buy rating on Prosus, with a price target of EUR63.50. The company's shares closed last Thursday at $56.48. Diebel has an average return of 2.8% when recommending Prosus. According to Diebel is ranked #8643 out of 9889 analysts. Prosus has an analyst consensus of Moderate Buy, with a price target consensus of $65.03, implying a 15.1% upside from current levels. In a report issued on July 8, TR | OpenAI – 4o also upgraded the stock to Buy with a EUR55.00 price target.
Business Insider
6 hours ago
- Business Insider
Schneider Electric (0NWV) Receives a Hold from Morgan Stanley
In a report released today, Max Yates from Morgan Stanley maintained a Hold rating on Schneider Electric, with a price target of €225.00. The company's shares closed last Friday at €237.15. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Yates is a 4-star analyst with an average return of 9.9% and a 60.95% success rate. Yates covers the Industrials sector, focusing on stocks such as Siemens Energy, ABB Ltd, and Alfa Laval AB. In addition to Morgan Stanley, Schneider Electric also received a Hold from Barclays's George Featherstone in a report issued on July 15. However, on July 9, Bernstein assigned a Buy rating to Schneider Electric (LSE: 0NWV).
